Literature DB >> 33647370

Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.

Gregor Manukian1, Charles Kivolowitz1, Tiziana DeAngelis1, Anuradha A Shastri1, Jason E Savage2, Kevin Camphausen2, Ulrich Rodeck3, Jelani C Zarif4, Nicole L Simone5.   

Abstract

Outcomes for triple negative breast cancer (TNBC) are poor and may be improved by increasing CD8+ tumor infiltrating lymphocytes (TIL) to augment antitumor immunity. Radiation (RT) can promote immunogenic cell death with increased antitumor T cell activity but also stimulates suppressive regulatory T cells (Tregs). Because metabolic alterations affect immune homeostasis and prior studies show caloric restriction (CR) combined with RT improves preclinical TNBC outcomes, we hypothesized that CR augments RT, in part, by altering intratumoral immunity. Using an in vivo model of TNBC, we treated mice with ad libitum (AL) diet, radiation, a CR diet, or CR + RT, and demonstrated an immune suppressive environment with a significant increase in CD4+ CD25+Foxp3+ Tregs after RT but not in CR-fed mice. CD8:Treg ratio in CR + RT TIL increased 4-fold compared with AL + RT mice. In vivo CD8 depletion was performed to assess the role of effector T cells in mitigating the effects of CR, and it was found that in mice undergoing CR, depletion of CD8 T cells resulted in increased tumor progression and decreased median survival compared with isotype control-treated mice. In addition, PD-1 expression on CD3+CD8+ T cells within the tumor microenvironment was significantly increased in CR + RT versus AL + RT treated mice as per immunofluorescence. Serum from breast cancer patients undergoing RT alone or CR and RT was collected pre- and postintervention, and a cytokine array demonstrated that patients treated with CR + RT had notable decreases in immunosuppressive cytokines such as IL-2Rγ, IL-10Rβ, and TGF-β2 and 3 compared with patients receiving RT alone. In conclusion, combining CR with RT decreases intratumoral Tregs, increases CD8:Treg, and increases PD-1 expression via a process dependent on CD8 T cells in a TNBC model. Breast cancer patients undergoing CR concurrently with RT also had significant reduction in immunosuppressive cytokine levels compared with those receiving RT alone.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33647370      PMCID: PMC8286289          DOI: 10.1016/j.ijrobp.2021.02.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   8.013


  39 in total

1.  CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.

Authors:  Padmanee Sharma; Yu Shen; Sijin Wen; Sachiko Yamada; Achim A Jungbluth; Sacha Gnjatic; Dean F Bajorin; Victor E Reuter; Harry Herr; Lloyd J Old; Eiichi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

2.  PD-L1 expression in triple-negative breast cancer.

Authors:  Elizabeth A Mittendorf; Anne V Philips; Funda Meric-Bernstam; Na Qiao; Yun Wu; Susan Harrington; Xiaoping Su; Ying Wang; Ana M Gonzalez-Angulo; Argun Akcakanat; Akhil Chawla; Michael Curran; Patrick Hwu; Padmanee Sharma; Jennifer K Litton; Jeffrey J Molldrem; Gheath Alatrash
Journal:  Cancer Immunol Res       Date:  2014-01-10       Impact factor: 11.151

3.  CD8+ cytotoxic and FoxP3+ regulatory T lymphocytes serve as prognostic factors in breast cancer.

Authors:  Gong-Ling Peng; Liang Li; Ya-Wen Guo; Pan Yu; Xing-Jie Yin; Shan Wang; Chun-Ping Liu
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

4.  Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model.

Authors:  Brittany A Simone; Ajay Palagani; Kimberly Strickland; Kevin Ko; Lianjin Jin; Meng Kieng Lim; Tu D Dan; Mak Sarich; Daniel A Monti; Massimo Cristofanilli; Nicole L Simone
Journal:  Cell Cycle       Date:  2018-08-06       Impact factor: 4.534

5.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

Review 6.  PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.

Authors:  Hashem O Alsaab; Samaresh Sau; Rami Alzhrani; Katyayani Tatiparti; Ketki Bhise; Sushil K Kashaw; Arun K Iyer
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

7.  Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.

Authors:  Raziye Piranlioglu; EunMi Lee; Maria Ouzounova; Roni J Bollag; Alicia H Vinyard; Ali S Arbab; Daniela Marasco; Mustafa Guzel; John K Cowell; Muthushamy Thangaraju; Ahmed Chadli; Khaled A Hassan; Max S Wicha; Esteban Celis; Hasan Korkaya
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

8.  Caloric restriction augments radiation efficacy in breast cancer.

Authors:  Anthony D Saleh; Brittany A Simone; Juan Palazzo; Jason E Savage; Yuri Sano; Tu Dan; Lianjin Jin; Colin E Champ; Shuping Zhao; Meng Lim; Frederica Sotgia; Kevin Camphausen; Richard G Pestell; James B Mitchell; Michael P Lisanti; Nicole L Simone
Journal:  Cell Cycle       Date:  2013-05-21       Impact factor: 4.534

9.  The effects of short-term calorie restriction on mutations in the spleen cells of infant-irradiated mice.

Authors:  Saori Kakomi; Takafumi Nakayama; Yi Shang; Chizuru Tsuruoka; Masaaki Sunaoshi; Takamitsu Morioka; Yoshiya Shimada; Shizuko Kakinuma; Akira Tachibana
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

Review 10.  PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition.

Authors:  Yilun Wu; Weiyu Chen; Zhi Ping Xu; Wenyi Gu
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

View more
  7 in total

1.  Replenishment of myeloid-derived suppressor cells (MDSCs) overrides CR-mediated protection against tumor growth in a murine model of triple-negative breast cancer.

Authors:  Melissa Carpenter; Dolly Chowdhury; Priya Krishna; Sandy Ng; Laura C D Pomatto-Watson; Monica Bodogai; Oye Bosompra; Jonathan Kato; Sarah Wong; Carlos Reyes-Sepulveda; Michel Bernier; Nathan L Price; Arya Biragyn; Rafael de Cabo
Journal:  Geroscience       Date:  2022-08-23       Impact factor: 7.581

Review 2.  Metabolic communication in the tumour-immune microenvironment.

Authors:  Kung-Chi Kao; Stefania Vilbois; Chin-Hsien Tsai; Ping-Chih Ho
Journal:  Nat Cell Biol       Date:  2022-10-13       Impact factor: 28.213

Review 3.  Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma.

Authors:  Taiana Campos Leite; Rebecca Jean Watters; Kurt Richard Weiss; Giuseppe Intini
Journal:  J Transl Med       Date:  2021-10-29       Impact factor: 5.531

4.  Daily caloric restriction limits tumor growth more effectively than caloric cycling regardless of dietary composition.

Authors:  Oye Bosompra; Jonathan Kato; Sarah Wong; Melissa Carpenter; Eleonora Duregon; Laura C D Pomatto-Watson; Monica Bodogai; Dolly Chowdhury; Priya Krishna; Sandy Ng; Emeline Ragonnaud; Roberto Salgado; Paula Gonzalez Ericsson; Alberto Diaz-Ruiz; Michel Bernier; Nathan L Price; Arya Biragyn; Valter D Longo; Rafael de Cabo
Journal:  Nat Commun       Date:  2021-10-27       Impact factor: 14.919

Review 5.  Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications.

Authors:  Shantel Angstadt; Qingfeng Zhu; Elizabeth M Jaffee; Douglas N Robinson; Robert A Anders
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 5.738

Review 6.  Calorie Restriction for Cancer Prevention and Therapy: Mechanisms, Expectations, and Efficacy.

Authors:  Chiara Vidoni; Alessandra Ferraresi; Andrea Esposito; Chinmay Maheshwari; Danny N Dhanasekaran; Vincenzo Mollace; Ciro Isidoro
Journal:  J Cancer Prev       Date:  2021-12-30

Review 7.  Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity.

Authors:  Nadia de Gruil; Hanno Pijl; Sjoerd H van der Burg; Judith R Kroep
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.